CI
Cardlytics, Inc. (CDLX)·Q3 2025 Earnings Summary
Executive Summary
- Q3 2025 revenue was $52.0M, down 22% YoY and slightly below the prior guidance low-end ($52.2–$58.2M), while Adjusted EBITDA of $3.2M was above the high end of guidance, reflecting a leaner cost base and improved partner mix .
- The company executed a 30% workforce reduction in October, targeting at least $26M in annualized cash savings and guiding Q4 Operating Expenses to $27–$28M (ex-SBC/severance), supporting positive Adjusted EBITDA expectation for Q4 and FY25 .
- Content restrictions at the largest FI partner pressured billings and U.S. revenue; mitigation includes shifting volume to other FI partners, expanding CRP non-FI supply (e.g., OpenTable), and deeper engagement initiatives (category-level offers, “Double Days”) .
- KPIs mixed: MQUs rose 21% YoY to 230.3M, but ACPU fell to $0.11 from $0.16; Adjusted Contribution margin hit a record 57.7% of revenue on improved bank economics; UK revenue grew 22% YoY .
- Near-term stock catalysts: Q4 guide implies positive EBITDA despite top-line pressure; rapid progress shifting to a high-margin FI mix and CRP partner launches; execution on supply diversification and engagement could drive estimate revisions and sentiment .
What Went Well and What Went Wrong
What Went Well
- Record Adjusted Contribution margin as % of revenue (57.7%) driven by improved bank mix; Adjusted EBITDA of $3.2M beat the prior guidance range high and turned positive YoY .
- MQUs rose 21% YoY to 230.3M, reflecting full ramp of new FI partners; UK revenue grew 22% YoY with new logos and larger budgets from top accounts .
- Strategic reset and cost actions: 30% workforce reduction and other spend cuts expected to deliver at least $26M annualized savings; CEO: “reset our business…set ourselves on a viable path to return to growth” .
What Went Wrong
- Revenue declined 22% YoY to $52.0M; ACPU compressed to $0.11 from $0.16 YoY as largest FI partner blocked advertiser content, driving billings declines and margin choppiness early in the quarter .
- U.S. revenue (ex-Bridg) fell 28%; Bridg revenue declined 15% due to a lost major account in prior quarters, highlighting ongoing category and account concentration risks .
- GAAP results burdened by a $58.8M impairment of goodwill and intangibles, contributing to a GAAP net loss of $(72.7)M and GAAP diluted EPS of $(1.36) .
Financial Results
Segment breakdown (platform):
KPIs:
Guidance Changes
Q4 2025 Guidance:
Q3 2025 Actual vs Prior Guidance (set on Aug 6):
Earnings Call Themes & Trends
Management Commentary
- CEO: “In Q3, we've taken decisive action that we believe will reset our business, improve our financial health, and set ourselves on a viable path to return to growth…prioritizing initiatives that build on our fundamental strengths and where we believe we can win” .
- CFO: “We surpassed the high end of our guidance for adjusted EBITDA…adjusted contribution as a percentage of revenue to 57.7%, the highest we have experienced to date, driven primarily by growth of our newest FI partners” .
- CEO: “Approximately one-third of our total billings were set to be blocked…but we were able to mitigate a significant portion of the drop because the rest of our network is more than 2.5x larger than our largest FI partner alone” .
- CFO on cost base: “For the fourth quarter, we expect operating expenses to be at or below $28 million, excluding stock-based compensation and severance…a $3–$4 million sequential improvement quarter over quarter” .
Q&A Highlights
- Margins: Management attributed Q3 billings-to-revenue margin weakness largely to July’s abrupt supply changes; margins normalized by quarter-end, with October run-rate higher; Adjusted Contribution margin at ~58% expected to be stable/high-50s given favorable bank mix .
- Guidance puts/takes: The $7M Adjusted EBITDA range is driven by top-line and margin variability; OpEx guided $27–$28M, with limited variance, implying flow-through sensitivity to revenue/contribution .
- Mitigation progress: Nearly 3x advertisers activated on the newest large FI partner vs Q1; October billings ~50% higher than Q3; activation rate is 2x network average .
Estimates Context
Values retrieved from S&P Global.*
Note: Company-reported Adjusted EBITDA was $3.2M , while consensus often tracks EPS and revenue. Where non-GAAP (Adjusted) metrics are central to the narrative, we anchor to company disclosures and reconciliations.
Where estimates may adjust:
- Potential upward bias to EBITDA/Adjusted Contribution assumptions given high margin retention and cost base reset; downward bias to U.S. revenue/ACPU near-term reflecting FI content restrictions and strategic pricing .
Key Takeaways for Investors
- Execution beat on profitability: Adjusted EBITDA above guidance high despite revenue headwinds; cost actions and bank mix support continued EBITDA positivity into Q4 and FY25 .
- Supply shift is working: Rapid advertiser activation and higher October billings at the newest large FI partner underpin mitigation of the largest FI restriction; watch pacing into Q4/Q1 .
- Pricing and engagement: Strategic pricing funded by higher-margin bank mix is driving ROAS and retention; category-level offers and “Double Days” lift engagement (e.g., ~15% engagement uptick) .
- UK resilience: 22% YoY revenue growth with all top five grocers on platform provides diversification and a bright spot amidst U.S. headwinds .
- Non-FI expansion: CRP (e.g., OpenTable) broadens supply and could unlock new advertiser categories in 2026; 2025 financial impact minimal but strategically important .
- Watch impairments vs adjusted metrics: Large non-cash impairment weighed on GAAP results; focus on Adjusted Contribution, margin, and cash metrics for operating trajectory .
- Near-term trading lens: Stock likely sensitive to execution on Q4 guide (revenue/billings margin in low 60s; Adjusted Contribution margin mid–high 50s), evidence of continued advertiser retention and CRP launches, and any updates on FI partner restrictions easing .